[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352762-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352762-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-global-burden-of-early-onset-cancer-in-women-19902021-findings-from-the-gbd-2021-with-focus-on-china","The global burden of early-onset cancer in women, 1990–2021: findings from the GBD 2021 with focus on China","","Early-onset cancer remains a major public health threat among women, while global evidence on its burden and time trends has been insufficient. This study quantified global incidence, mortality, and DALYs for female early-onset cancers (ages 15–49) from 1990–2021 using GBD 2021, reporting counts and age-standardized rates for 31 malignancies, with uncertainty intervals and trend estimation. Autoregressive models projected future burden to 2050, assessing links with SDI and comparing risk-attributable shares.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-global-burden-of-early-onset-cancer-in-women-19902021-findings-from-the-gbd-2021-with-focus-on-china/352762/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-global-burden-of-early-onset-cancer-in-women-19902021-findings-from-the-gbd-2021-with-focus-on-china/352762.png","ImageObject",300,407,{"name":42,"@type":43},"Taylor Morgan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What cancers and age range were analyzed in the study?","Question",{"text":63,"@type":64},"The study analyzed incidence, mortality, and DALYs for female early-onset cancers in ages 15–49 years.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data source and countries’ stratification were used?",{"text":68,"@type":64},"Analyses used Global Burden of Disease (GBD) 2021 data. Countries were stratified by socio-demographic index (SDI) quintiles.",{"name":70,"@type":61,"acceptedAnswer":71},"How were future trends projected, and what key projection results were reported?",{"text":72,"@type":64},"Future burden was projected to 2050 using ARIMA models. The age-standardized incidence rate was projected to peak around 2027 and then stabilize, while age-standardized mortality was projected to decline to 23.74 per 100,000 by 2050.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352762,1790120073,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Journal of the National Cancer Center 6 (2026) 149–158  \nContents lists available at ScienceDirect  \nJournal of the National Cancer Center  \njournal [homepage:](homepage: www.elsevier.com/locate/jncc)[ www.elsevier.com/locate/jncc](homepage: www.elsevier.com/locate/jncc)  \n| Full Length Article |  |  |  |\n| --- | --- | --- | --- |\n| The global burden of early-onset cancer in women, 1990–2021: ﬁndings from the GBD 2021 with focus on China |  |  | |\n| Yibei Li a,†, Danqi Huang a,†, Jingyi Liu a, Yang Baib, Bobo Zheng c, Quan Wangd, Wenbo Meng e, Jinqiu Yuanf, Min Yangg, Jingbo Zhai h, Jiang Li a,∗\u003Cbr>a Oﬃce of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China\u003Cbr>b The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China c Department of General Surgery, Shaanxi Provincial People’s Hospital, Xi’an, China d Ambulatory Surgery Center of Xijing Hospital, Fourth Military Medical University, Xi’an, China e Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China\u003Cbr>f Department of Epidemiology and Biostatistics, Clinical Big Data Research Center, The Seventh Aﬃliated Hospital, Sun Yat-sen University, Shenzhen, China g Department of Comprehensive Intervention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China\u003Cbr>h School of Public Health, Tianjin University of Traditional Chinese Medicine, Tianjin, China |  |  |  |\n| a r t i c l e i n f o |  | a b s t r a c t |  |\n| Keywords:\u003Cbr>Early-onset cancer\u003Cbr>Female\u003Cbr>Global burden of disease study Modiﬁable risks\u003Cbr>Burden projection |  | Background: Early-onset cancer is a signiﬁcant public health threat in females, yet comprehensive data on its global burden and temporal trends remain limited. Our study aimed to provide a comprehensive assessment of global burden of female early-onset cancer from 1990 to 2021, and to project its change to 2050.\u003Cbr>Methods: This study analyzed the incidence, mortality, and disability-adjusted life years (DALYs) of female earlyonset cancers (ages 15–49 years) from 1990 to 2021, with projections to 2050, using Global Burden of Disease (GBD) 2021 data. We presented absolute counts and age-standardized rates (ASRs) per 100,000 population for 31 malignancies with 95% uncertainty intervals (UIs). Estimated annual percentage changes (EAPCs) quantiﬁed temporal trends in ASRs, while Autoregressive Integrated Moving Average (ARIMA) models projected future burden. Countries were stratiﬁed by socio-demographic index (SDI) quintiles, and Spearman rank correlation analysis and Frontier analysis were used to explore the relationship between SDI and disease burden. Risk-attributable burden was assessed through GBD’s comparative risk framework.\u003Cbr>Results: From 1990 to 2021, the number of global new cases of female early-onset cancers rose from 11.49 to 17.06 million, and the number of deaths increased from 0.40 million to 0.51 million. Early-onset breast cancer had the highest burden, followed by cervical cancer. Globally, the age-standardized incidence rate (ASIR) showed a slight decline with the EAPC of-0.13%, whereas the United States saw a signiﬁcant rise (EAPC = 1.36%). The age-standardized mortality rate (ASMR) declined signiﬁcantly (EAPC = -1.14%), with China experiencing a steep reduction (EAPC = -2.09%). Modiﬁable risk factors accounted for 31.44% of total deaths in 2021, concentrated in cervical (100% of its deaths attributable to modiﬁable risk factors), lung (50.05%), and colorectal cancers (50.85%). Projections indicated that ASIR would peak at 880.95 per 100,000 by 2027 and subsequently stabilize, while ASMR would decline to 23.74 per 100,000 by 2050.\u003Cbr>Conclusions: The ﬁndings of this study characterize the global disease burden of early-onset cancers","cbCaigZaBg6Zt990","https://ap.wps.com/l/cbCaigZaBg6Zt990","pdf",1923958,"English","# Introduction\n# Methods\n## Data source and outcomes\n## Statistical modeling and risk attribution\n# Results\n## Incidence and mortality trends\n## Leading cancer types and risk factors\n## Projections to 2050\n# Conclusions","[{\"question\":\"What cancers and age range were analyzed in the study?\",\"answer\":\"The study analyzed incidence, mortality, and DALYs for female early-onset cancers in ages 15–49 years.\"},{\"question\":\"Which data source and countries’ stratification were used?\",\"answer\":\"Analyses used Global Burden of Disease (GBD) 2021 data. Countries were stratified by socio-demographic index (SDI) quintiles.\"},{\"question\":\"How were future trends projected, and what key projection results were reported?\",\"answer\":\"Future burden was projected to 2050 using ARIMA models. The age-standardized incidence rate was projected to peak around 2027 and then stabilize, while age-standardized mortality was projected to decline to 23.74 per 100,000 by 2050.\"}]","The global burden of early-onset cancer in women, 1990–2021: findings from the GBD 2021 with focus on China | PDF",1790101267,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1fe40a9dc1acac13f4b29038252cd50e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a58a63e75e386f7416e295128b012fd.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae3baa633bd3c942d5402cff3da4cf88.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67f17350f6f77b88c9c2359933894288.webp",980,1306]